JPM Thematics - Genetic Therapies C2 Fonds
91,42
EUR
+1,38
EUR
+1,53
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,49% |
| Gilead Sciences Inc | US3755581036 | 3,41% |
| Novartis AG Registered Shares | CH0012005267 | 3,35% |
| Bio-Techne Corp | US09073M1045 | 3,15% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,00% |
| Amgen Inc | US0311621009 | 2,91% |
| Lonza Group Ltd | CH0013841017 | 2,87% |
| Arcellx Inc | US03940C1009 | 2,84% |
| Krystal Biotech Inc | US5011471027 | 2,84% |
| Sarepta Therapeutics Inc | US8036071004 | 2,66% |
| Sonstige | 69,48% |